OTC Markets Group Welcomes Somerset Trust Holding Company to OTCQX

OTC Markets Group Welcomes Somerset Trust Holding Company to OTCQX GlobeNewswire July 09, 2025 NEW YORK, July 09, 2025 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Somerset Trust Holding Company (OTCQX: SOME) (the “Company”), the holding company of Somerset Trust […]

OTC Markets Group Welcomes Whitecap Resources Inc. to OTCQX

OTC Markets Group Welcomes Whitecap Resources Inc. to OTCQX GlobeNewswire July 09, 2025 NEW YORK, July 09, 2025 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Whitecap Resources Inc. (TSX: WCP; OTCQX: WCPRF), a leading Canadian oil & natural gas company,

MADD Canada Unveils Roadside Memorial Sign in Niagara-on-the-Lake in Honour of Ashley Marie Vaillancourt Killed in Impaired Driving Crash

MADD Canada Unveils Roadside Memorial Sign in Niagara-on-the-Lake in Honour of Ashley Marie Vaillancourt Killed in Impaired Driving Crash GlobeNewswire July 09, 2025 OAKVILLE, Ontario, July 09, 2025 (GLOBE NEWSWIRE) — Today, MADD Canada will unveil a new roadside memorial sign in Niagara-on-the-Lake in honour of 34-year-old Ashley Marie Vaillancourt, who was tragically killed in

Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study of M4 Positive Allosteric Modulator NMRA-861

Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study of M4 Positive Allosteric Modulator NMRA-861 GlobeNewswire July 09, 2025 NMRA-861 has potential best-in-class pharmacology, which may enable a more favorable therapeutic profile No convulsions observed in pre-clinical studies conducted in multiple species, including rabbits WATERTOWN, Mass., July 09, 2025 (GLOBE NEWSWIRE) — Neumora Therapeutics, Inc.

HRCI Launches HRCI CHAT: AI-Powered Assistant to Revolutionize HR Workflows

HRCI Launches HRCI CHAT: AI-Powered Assistant to Revolutionize HR Workflows New Resource Provides 24/7 Support Focused Exclusively on HR Needs GlobeNewswire July 09, 2025 ALEXANDRIA, Va., July 09, 2025 (GLOBE NEWSWIRE) — HRCI, the premier credentialing and learning community for the human resource profession, today announced its newest AI-powered resource, HRCI CHAT. Available on a

Purespring Therapeutics announce FDA IND clearance for Phase I/II clinical trial for primary IgA nephropathy (IgAN)

Purespring Therapeutics announce FDA IND clearance for Phase I/II clinical trial for primary IgA nephropathy (IgAN) GlobeNewswire July 09, 2025 PS-002, Purespring's lead precision nephrology programme, targets the complement pathway known to be a driver of IgA nephropathy IND clearance follows the granting of European Medicine Agency (EMA) orphan drug designation in April 2025 First

Evergold Enhances the Copper Potential of its Golden Lion Property in BC’s Toodoggone Region by Acquiring 100% of the Copper King Inlier Prospects, Plans Share Consolidation

Evergold Enhances the Copper Potential of its Golden Lion Property in BC's Toodoggone Region by Acquiring 100% of the Copper King Inlier Prospects, Plans Share Consolidation GlobeNewswire July 09, 2025 TORONTO, July 09, 2025 (GLOBE NEWSWIRE) — Evergold Corp. (TSX-V: EVER, WKN: A2PTHZ) (“Evergold” or the “Company“) is pleased to announce that it has entered

HPQ Silicon Fast-Tracks North American Battery Production–Targets Q3 Launch

HPQ Silicon Fast-Tracks North American Battery Production–Targets Q3 Launch A newly signed agreement with Novacium marks the start of HPQ's path to commercializing its high-performance battery technology in North America GlobeNewswire July 09, 2025 MONTREAL, July 09, 2025 (GLOBE NEWSWIRE) — HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), a

Axsome Therapeutics to Report Second Quarter 2025 Financial Results on August 4

Axsome Therapeutics to Report Second Quarter 2025 Financial Results on August 4 GlobeNewswire July 09, 2025 NEW YORK, July 09, 2025 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced it will report its financial results for the

Palantir and Tomorrow.io Partner to Operationalize Global Weather Intelligence and Agentic AI

Palantir Technologies Inc. (NASDAQ: PLTR), a leading provider of enterprise operating systems, and Tomorrow.io, a leading weather intelligence and resilience platform, today announced a partnership with the aim to reshape the future of weather intelligence and operational readiness. The partnership will integrate Tomorrow.io's proprietary data and predictive insights into Palantir's industry-leading platforms, enabling end-to-end automated

Scroll to Top